• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    4/20/22 12:14:38 PM ET
    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACLX alert in real time by email

     

    On Wednesday, 160 companies hit new 52-week lows.

    Areas of Significance In Today's 52-Week Lows:

    • Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new 52-week low.
    • Vallon Pharmaceuticals (NASDAQ:VLON) is the smallest company on a market cap basis to set a new 52-week low.
    • Netflix (NASDAQ:NFLX)'s stock came under the most pressure, trading down 36.5% to reach a new 52-week low.
    • Oncorus (NASDAQ:ONCR) shares bounced back the most, actually rising 0.07% after hiting a new 52-week low.

    The following stocks set new 52-week lows on Wednesday:

    • Walt Disney (NYSE:DIS) stock dropped to a yearly low on Wednesday of $124.65. Shares traded down 4.5%.
    • Netflix (NASDAQ:NFLX) shares hit a yearly low of $212.51. The stock was down 36.5% on the session.
    • Pinterest (NYSE:PINS) stock hit a new 52-week low of $21.20. The stock was down 4.93% on the session.
    • Etsy (NASDAQ:ETSY) stock dropped to a yearly low on Wednesday of $105.75. Shares traded down 7.72%.
    • IAC/InterActive (NASDAQ:IAC) stock set a new 52-week low of $93.50 on Wednesday, moving down 2.74%.
    • Carvana (NYSE:CVNA) shares made a new 52-week low of $92.89 on Wednesday. The stock was down 7.84% for the day.
    • SoFi Technologies (NASDAQ:SOFI) shares hit a yearly low of $6.93. The stock was down 6.01% on the session.
    • Grupo Aval Acciones (NYSE:AVAL) shares were down 0.25% for the day, having made a 52-week low of $4.21.
    • Innovative Industrial (NYSE:IIPR) stock broke to a new 52-week low of $162.44 on Wednesday. Shares of the company traded up 0.78%.
    • ironSource (NYSE:IS) shares were down 4.0% for the day, having made a 52-week low of $4.37.
    • Intellia Therapeutics (NASDAQ:NTLA) stock hit $55.06 on Wednesday morning, setting a new 52-week low for a change of down 1.91%.
    • Denali Therapeutics (NASDAQ:DNLI) shares set a new yearly low of $27.78 this morning. The stock was down 0.46% on the session.
    • Beam Therapeutics (NASDAQ:BEAM) shares moved down 2.77% on Wednesday to hit a new 52-week low of $42.55, drifting down 2.77%.
    • Roivant Sciences (NASDAQ:ROIV) shares hit a yearly low of $3.72. The stock was down 4.28% on the session.
    • Duck Creek Technologies (NASDAQ:DCT) shares set a new yearly low of $17.17 this morning. The stock was down 3.24% on the session.
    • Pacific Biosciences (NASDAQ:PACB) shares set a new 52-week low of $7.01. The stock traded down 3.63%.
    • iRobot (NASDAQ:IRBT) stock hit a yearly low of $50.91. The stock was down 0.32% for the day.
    • Morphic Holding (NASDAQ:MORF) shares were down 4.99% for the day, having made a 52-week low of $33.77.
    • Rocket Companies (NYSE:RKT) stock hit $9.13 on Wednesday morning, setting a new 52-week low for a change of up 1.95%.
    • Starry Group Holdings (NYSE:STRY) stock hit a new 52-week low of $6.14. The stock was up 0.76% on the session.
    • Velo3D (NYSE:VLD) stock hit $4.69 on Wednesday morning, setting a new 52-week low for a change of up 0.73%.
    • Coherus BioSciences (NASDAQ:CHRS) stock achieved a new 52-week low on Wednesday morning, hitting $10.06 and moving down 2.89%.
    • National Energy Services (NASDAQ:NESR) shares set a new yearly low of $7.95 this morning. The stock was down 0.98% on the session.
    • Blackrock Muniholdings (NYSE:MHD) stock broke to a new 52-week low of $13.07 on Wednesday. Shares of the company traded down 0.3%.
    • Excelerate Energy (NYSE:EE) shares set a new yearly low of $25.59 this morning. The stock was down 1.79% on the session.
    • Invesco Mortgage Capital (NYSE:IVR) stock set a new 52-week low of $1.80 on Wednesday, moving up 2.75%.
    • Orchid Island Cap (NYSE:ORC) shares moved up 2.05% on Wednesday to hit a new 52-week low of $2.86, drifting up 2.05%.
    • Swvl Hldgs (NASDAQ:SWVL) stock hit $4.17 on Wednesday morning, setting a new 52-week low for a change of up 2.82%.
    • Porch Group (NASDAQ:PRCH) stock set a new 52-week low of $4.83 on Wednesday, moving down 4.62%.
    • Arcellx (NASDAQ:ACLX) shares reached a new 52-week low of $12.00 on Wednesday morning, moving down 4.6%.
    • Volta (NYSE:VLTA) shares set a new 52-week low of $2.44. The stock traded down 8.52%.
    • Ideanomics (NASDAQ:IDEX) shares set a new 52-week low of $0.80. The stock traded down 1.76%.
    • Meta Materials (NASDAQ:MMAT) stock hit $1.37 on Wednesday morning, setting a new 52-week low for a change of down 2.97%.
    • Tyra Biosciences (NASDAQ:TYRA) shares hit a yearly low of $8.75. The stock was up 0.32% on the session.
    • Revlon (NYSE:REV) stock hit $7.10 on Wednesday morning, setting a new 52-week low for a change of down 4.28%.
    • Praxis Precision Medicine (NASDAQ:PRAX) shares hit a yearly low of $7.90. The stock was down 0.97% on the session.
    • Nuveen New York Quality (NYSE:NAN) stock hit a yearly low of $11.58. The stock was up 0.6% for the day.
    • AFC Gamma (NASDAQ:AFCG) shares set a new yearly low of $17.79 this morning. The stock was up 0.39% on the session.
    • SelectQuote (NYSE:SLQT) stock broke to a new 52-week low of $1.96 on Wednesday. Shares of the company traded down 2.63%.
    • Precigen (NASDAQ:PGEN) shares set a new yearly low of $1.58 this morning. The stock was down 1.23% on the session.
    • Blackrock Municipal (NYSE:BYM) stock broke to a new 52-week low of $12.45 on Wednesday. Shares of the company traded up 0.88%.
    • FTC Solar (NASDAQ:FTCI) shares hit a yearly low of $3.23. The stock was down 5.69% on the session.
    • Blackrock Income Trust (NYSE:BKT) shares set a new yearly low of $4.87 this morning. The stock was down 0.31% on the session.
    • MFS Charter Income (NYSE:MCR) stock hit $6.84 on Wednesday morning, setting a new 52-week low for a change of up 0.15%.
    • Ocular Therapeutix (NASDAQ:OCUL) stock hit $3.90 on Wednesday morning, setting a new 52-week low for a change of down 0.53%.
    • Omeros (NASDAQ:OMER) shares fell to $4.35 on Wednesday, setting a new 52-week low with a shift of down 7.45%.
    • Nkarta (NASDAQ:NKTX) stock hit $8.00 on Wednesday morning, setting a new 52-week low for a change of down 4.03%.
    • Western Asset Inflation (NYSE:WIA) stock hit $11.12 on Wednesday morning, setting a new 52-week low for a change of up 0.18%.
    • Allakos (NASDAQ:ALLK) stock set a new 52-week low of $4.57 on Wednesday, moving down 0.83%.
    • Vroom (NASDAQ:VRM) shares hit a yearly low of $1.80. The stock was down 8.12% on the session.
    • Oramed Pharmaceuticals (NASDAQ:ORMP) shares moved down 4.3% on Wednesday to hit a new 52-week low of $6.24, drifting down 4.3%.
    • Gritstone Bio (NASDAQ:GRTS) stock set a new 52-week low of $3.22 on Wednesday, moving down 2.65%.
    • Omega Therapeutics (NASDAQ:OMGA) shares set a new 52-week low of $4.92. The stock traded down 3.13%.
    • eHealth (NASDAQ:EHTH) stock set a new 52-week low of $8.47 on Wednesday, moving down 4.01%.
    • Neuberger Berman (AMEX:NBH) shares fell to $12.05 on Wednesday, setting a new 52-week low with a shift of up 0.39%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) stock drifted down 1.12% on Wednesday morning to hit a new 52-week low of $6.82.
    • Pioneer Municipal High IT (NYSE:MHI) stock broke to a new 52-week low of $9.63 on Wednesday. Shares of the company traded up 0.72%.
    • Compugen (NASDAQ:CGEN) shares hit a yearly low of $2.52. The stock was down 3.07% on the session.
    • Citizens (NYSE:CIA) stock set a new 52-week low of $3.88 on Wednesday, moving down 1.39%.
    • Bit Digital (NASDAQ:BTBT) stock drifted down 5.66% on Wednesday morning to hit a new 52-week low of $2.58.
    • Applied Molecular (NASDAQ:AMTI) shares hit a yearly low of $4.85. The stock was down 4.32% on the session.
    • American Superconductor (NASDAQ:AMSC) stock achieved a new 52-week low on Wednesday morning, hitting $6.55 and moving down 3.67%.
    • BIT Mining (NYSE:BTCM) shares made a new 52-week low of $2.27 on Wednesday. The stock was down 4.96% for the day.
    • Kopin (NASDAQ:KOPN) stock drifted down 0.28% on Wednesday morning to hit a new 52-week low of $1.73.
    • GTY Technology Holdings (NASDAQ:GTYH) shares reached a new 52-week low of $2.75 on Wednesday morning, moving down 7.67%.
    • Telesat (NASDAQ:TSAT) shares moved down 0.68% on Wednesday to hit a new 52-week low of $12.81, drifting down 0.68%.
    • Romeo Power (NYSE:RMO) stock dropped to a yearly low on Wednesday of $1.13. Shares traded down 1.54%.
    • Finance of America (NYSE:FOA) stock hit $2.43 on Wednesday morning, setting a new 52-week low for a change of up 0.2%.
    • Rubius Therapeutics (NASDAQ:RUBY) stock hit a yearly low of $1.53. The stock was down 0.94% for the day.
    • CytomX Therapeutics (NASDAQ:CTMX) stock hit a new 52-week low of $2.12. The stock was down 1.13% on the session.
    • Passage Bio (NASDAQ:PASG) stock hit a new 52-week low of $2.52. The stock was down 1.15% on the session.
    • First Eagle Alternative (NASDAQ:FCRD) stock achieved a new 52-week low on Wednesday morning, hitting $4.07 and moving down 2.85%.
    • Molecular Templates (NASDAQ:MTEM) shares set a new 52-week low of $2.12. The stock traded down 4.42%.
    • Biomea Fusion (NASDAQ:BMEA) stock broke to a new 52-week low of $4.01 on Wednesday. Shares of the company traded down 2.88%.
    • Ellington Residential (NYSE:EARN) stock hit $8.63 on Wednesday morning, setting a new 52-week low for a change of up 2.29%.
    • Homology Medicines (NASDAQ:FIXX) shares made a new 52-week low of $1.91 on Wednesday. The stock was down 6.34% for the day.
    • Adverum Biotechnologies (NASDAQ:ADVM) stock drifted down 1.79% on Wednesday morning to hit a new 52-week low of $1.09.
    • Sientra (NASDAQ:SIEN) stock dropped to a yearly low on Wednesday of $1.62. Shares traded up 0.29%.
    • Surface Oncology (NASDAQ:SURF) stock dropped to a yearly low on Wednesday of $2.24. Shares traded down 3.43%.
    • Magenta Therapeutics (NASDAQ:MGTA) shares fell to $1.79 on Wednesday, setting a new 52-week low with a shift of down 5.03%.
    • Tabula Rasa HealthCare (NASDAQ:TRHC) shares were down 4.12% for the day, having made a 52-week low of $4.04.
    • GoHealth (NASDAQ:GOCO) stock drifted down 3.36% on Wednesday morning to hit a new 52-week low of $0.81.
    • Celcuity (NASDAQ:CELC) stock drifted down 5.45% on Wednesday morning to hit a new 52-week low of $6.94.
    • Mereo BioPharma Group (NASDAQ:MREO) shares made a new 52-week low of $0.83 on Wednesday. The stock was down 2.07% for the day.
    • SQZ Biotechnologies (NYSE:SQZ) shares made a new 52-week low of $3.48 on Wednesday. The stock was down 3.5% for the day.
    • Kirkland's (NASDAQ:KIRK) shares fell to $8.07 on Wednesday, setting a new 52-week low with a shift of down 2.86%.
    • Pulse Biosciences (NASDAQ:PLSE) shares set a new yearly low of $3.06 this morning. The stock was down 2.07% on the session.
    • Sesen Bio (NASDAQ:SESN) shares made a new 52-week low of $0.47 on Wednesday. The stock was down 2.25% for the day.
    • SCYNEXIS (NASDAQ:SCYX) shares were down 3.36% for the day, having made a 52-week low of $3.13.
    • Western Asset Mortgage (NYSE:WMC) shares moved up 0.33% on Wednesday to hit a new 52-week low of $1.49, drifting up 0.33%.
    • PLx Pharma (NASDAQ:PLXP) stock broke to a new 52-week low of $3.13 on Wednesday. Shares of the company traded down 3.93%.
    • Codiak BioSciences (NASDAQ:CDAK) stock achieved a new 52-week low on Wednesday morning, hitting $3.60 and moving up 0.79%.
    • icad (NASDAQ:ICAD) shares were down 2.72% for the day, having made a 52-week low of $3.19.
    • Seelos Therapeutics (NASDAQ:SEEL) shares fell to $0.72 on Wednesday, setting a new 52-week low with a shift of down 1.12%.
    • Bolt Biotherapeutics (NASDAQ:BOLT) stock broke to a new 52-week low of $2.07 on Wednesday. Shares of the company traded down 4.82%.
    • Esports Technologies (NASDAQ:EBET) shares made a new 52-week low of $5.01 on Wednesday. The stock was down 3.37% for the day.
    • Athenex (NASDAQ:ATNX) stock set a new 52-week low of $0.65 on Wednesday, moving down 4.42%.
    • Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock dropped to a yearly low on Wednesday of $1.60. Shares traded down 1.82%.
    • Helbiz (NASDAQ:HLBZ) shares set a new 52-week low of $1.87. The stock traded down 5.34%.
    • S&W Seed (NASDAQ:SANW) shares reached a new 52-week low of $1.67 on Wednesday morning, moving down 1.16%.
    • NewAge (NASDAQ:NBEV) shares set a new 52-week low of $0.43. The stock traded down 1.49%.
    • Corvus Pharmaceuticals (NASDAQ:CRVS) stock broke to a new 52-week low of $1.30 on Wednesday. Shares of the company traded down 2.19%.
    • Trinity Place Hldgs (AMEX:TPHS) stock hit $1.51 on Wednesday morning, setting a new 52-week low for a change of up 2.58%.
    • Marygold Companies (AMEX:MGLD) stock broke to a new 52-week low of $1.43 on Wednesday. Shares of the company traded down 2.37%.
    • ProQR Therapeutics (NASDAQ:PRQR) shares moved down 1.41% on Wednesday to hit a new 52-week low of $0.74, drifting down 1.41%.
    • ASLAN Pharma (NASDAQ:ASLN) stock dropped to a yearly low on Wednesday of $0.73. Shares traded down 2.59%.
    • mCloud Technologies (NASDAQ:MCLD) stock hit a yearly low of $2.75. The stock was down 4.84% for the day.
    • Cabaletta Bio (NASDAQ:CABA) stock drifted up 2.67% on Wednesday morning to hit a new 52-week low of $1.48.
    • Gulf (NASDAQ:GURE) stock hit $3.99 on Wednesday morning, setting a new 52-week low for a change of down 2.2%.
    • Intellicheck (NASDAQ:IDN) shares were down 2.05% for the day, having made a 52-week low of $2.13.
    • Cyclerion Therapeutics (NASDAQ:CYCN) stock broke to a new 52-week low of $0.83 on Wednesday. Shares of the company traded down 6.32%.
    • Oncorus (NASDAQ:ONCR) stock dropped to a yearly low on Wednesday of $1.30. Shares traded down 0.07%.
    • HyreCar (NASDAQ:HYRE) shares were down 8.24% for the day, having made a 52-week low of $1.54.
    • Boqii Holding (NYSE:BQ) shares were down 5.33% for the day, having made a 52-week low of $0.32.
    • Biocept (NASDAQ:BIOC) stock hit $1.71 on Wednesday morning, setting a new 52-week low for a change of up 0.28%.
    • Calyxt (NASDAQ:CLXT) shares hit a yearly low of $0.53. The stock was down 6.44% on the session.
    • Rail Vision (NASDAQ:RVSN) shares set a new 52-week low of $1.41. The stock traded down 0.34%.
    • Engine Gaming And Media (NASDAQ:GAME) shares made a new 52-week low of $1.35 on Wednesday. The stock was down 9.16% for the day.
    • Rubicon Technology (NASDAQ:RBCN) shares hit a yearly low of $8.58. The stock was down 0.63% on the session.
    • RenovoRx (NASDAQ:RNXT) shares set a new yearly low of $2.25 this morning. The stock was down 4.83% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a new 52-week low of $1.66. The stock was up 0.6% on the session.
    • LogicBio Therapeutics (NASDAQ:LOGC) stock hit a yearly low of $0.60. The stock was down 0.1% for the day.
    • Crown ElectroKinetics (NASDAQ:CRKN) stock broke to a new 52-week low of $1.24 on Wednesday. Shares of the company traded up 2.36%.
    • Kintara Therapeutics (NASDAQ:KTRA) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 3.79% for the day.
    • Kubient (NASDAQ:KBNT) stock drifted up 0.92% on Wednesday morning to hit a new 52-week low of $1.13.
    • ShiftPixy (NASDAQ:PIXY) shares hit a yearly low of $0.47. The stock was down 2.57% on the session.
    • Jupai Hldgs (NYSE:JP) stock hit a new 52-week low of $0.41. The stock was down 10.2% on the session.
    • FedNat Holding (NASDAQ:FNHC) stock hit a yearly low of $0.85. The stock was up 3.74% for the day.
    • Motorsport Games (NASDAQ:MSGM) shares were down 4.89% for the day, having made a 52-week low of $1.05.
    • Vallon Pharmaceuticals (NASDAQ:VLON) shares hit a yearly low of $1.17. The stock was down 3.2% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $ADVM
    $AFCG
    $ALLK

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    Walt Disney Company
    $DIS
    2/3/2026$135.00Overweight
    Morgan Stanley
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    SoFi Technologies Inc.
    $SOFI
    2/2/2026$36.00 → $33.00Buy
    Needham
    Praxis Precision Medicines Inc.
    $PRAX
    2/2/2026$282.00Equal Weight
    Wells Fargo
    Pinterest Inc.
    $PINS
    1/30/2026$24.90Buy → Hold
    HSBC Securities
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    More analyst ratings

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    SEC Filings

    View All

    SEC Form 6-K filed by ProQR Therapeutics N.V.

    6-K - ProQR Therapeutics N.V. (0001612940) (Filer)

    2/9/26 8:07:21 AM ET
    $PRQR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Kopin Corporation

    SCHEDULE 13G - KOPIN CORP (0000771266) (Subject)

    2/9/26 6:44:29 AM ET
    $KOPN
    Semiconductors
    Technology

    SEC Form SCHEDULE 13G filed by Intellia Therapeutics Inc.

    SCHEDULE 13G - Intellia Therapeutics, Inc. (0001652130) (Subject)

    2/9/26 6:42:03 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SoFi Technologies upgraded by Citizens with a new price target

    Citizens upgraded SoFi Technologies from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    2/9/26 6:58:53 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Morgan Stanley resumed coverage on Walt Disney with a new price target

    Morgan Stanley resumed coverage of Walt Disney with a rating of Overweight and set a new price target of $135.00

    2/3/26 6:56:53 AM ET
    $DIS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SoFi Technologies upgraded by Analyst with a new price target

    Analyst upgraded SoFi Technologies from Neutral to Overweight and set a new price target of $31.00

    2/3/26 6:51:21 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sainz Maria

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:21:10 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Sainz Maria

    3 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:18:07 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BlackRock Announces Completion of Certain Municipal CEF Reorganizations and Adoption of Discount Management Program

    BlackRock Advisors, LLC announced today each of the closed-end funds named below (each, a "Fund" and collectively, the "Funds") have completed their reorganizations or mergers, as applicable (each, a "Reorganization" and collectively, the "Reorganizations"). Additionally, each of the Survivor Funds, as identified below, adopted a Discount Management Program that seeks to enhance long-term shareholder value via periodic liquidity events if certain conditions are met (see below for details). Reorganization of BlackRock California Municipal Income Trust (BFZ) with and into BlackRock MuniHoldings California Quality Fund, Inc. (MUC) Reorganizations of BlackRock New York Municipal Income Tr

    2/9/26 8:34:00 AM ET
    $BFK
    $BFZ
    $BLE
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    ProQR Announces Planned Changes to Board Composition

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that Dinko Valerio, a co-founder of the Company, and Alison Lawton will rotate off the Board at the Company's next Annual General Meeting (AGM) as their terms conclude.  The planned changes to ProQR's Board composition at its 2026 AGM reflect the Company's development as it advances its clinical programs, as well as its ongoing commitment to strong corporate governance and long-term succession planni

    2/9/26 8:00:00 AM ET
    $PRQR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC

    DUBAI, United Arab Emirates, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Swvl Holdings Corp ("Swvl" or the "Company") (NASDAQ:SWVL), a leading provider of technology-enabled mass mobility solutions, today announced the signing of a new three-year contract valued at up to $1.5 million in the Kingdom of Saudi Arabia ("KSA"), marking a significant expansion of its healthcare mobility operations across the Gulf Cooperation Council ("GCC"). The agreement will support patient, medical staff, and equipment transportation across healthcare facilities, leveraging Swvl's technology platform to enable dynamic route planning, real-time dispatching, and operational optimization. The deployment is designed to su

    2/9/26 7:00:00 AM ET
    $SWVL
    Real Estate

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    EVP GBUL Borrow Schuppenhauer Eric bought $99,650 worth of shares (5,000 units at $19.93), increasing direct ownership by 2% to 228,768 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/5/26 5:53:28 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    President, CEO and CFO Quinn William P. bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 6% to 2,313 units (SEC Form 4)

    4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)

    2/4/26 4:32:38 PM ET
    $BOLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Leadership Updates

    Live Leadership Updates

    View All

    ProQR Announces Planned Changes to Board Composition

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that Dinko Valerio, a co-founder of the Company, and Alison Lawton will rotate off the Board at the Company's next Annual General Meeting (AGM) as their terms conclude.  The planned changes to ProQR's Board composition at its 2026 AGM reflect the Company's development as it advances its clinical programs, as well as its ongoing commitment to strong corporate governance and long-term succession planni

    2/9/26 8:00:00 AM ET
    $PRQR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer

    MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, is pleased to announce the appointment of Mark Voll as the Company's Chief Financial Officer, effective February 1, 2026. Mr. Voll brings more than three decades of financial leadership experience to RenovoRx, with a strong track record for guiding high-growth public companies through periods of commercial buildout and strategic development. He has served as Chief Financial Officer for multiple publicly traded technology co

    2/5/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Josh D'Amaro Named Next Chief Executive Officer of The Walt Disney Company

    Dana Walden To Become President and Chief Creative Officer of The Walt Disney Company The Walt Disney Company (NYSE:DIS) Board of Directors announced today that, in a unanimous vote held on Monday, it elected Disney Experiences Chairman Josh D'Amaro to become Chief Executive Officer of The Walt Disney Company, effective at the upcoming Annual Meeting on March 18, 2026, when he will succeed longtime Disney CEO Robert A. Iger. The Board also intends to appoint D'Amaro as a director immediately following that meeting. As head of the company's largest business segment with $36 billion in annual revenue in FY2025 and 185,000 Cast Members and employees worldwide, D'Amaro, a 28-year Disney veter

    2/3/26 8:30:00 AM ET
    $DIS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Neuberger Berman Municipal Fund Inc.

    SC 13D/A - NEUBERGER BERMAN MUNICIPAL FUND INC. (0001178839) (Subject)

    12/13/24 4:42:44 PM ET
    $NBH
    Finance/Investors Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Financials

    Live finance-specific insights

    View All

    Bimini Capital Management to Announce Fourth Quarter 2025 Results

    VERO BEACH, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini" or the "Company"), today announced that it will release results for the fourth quarter of 2025 following the close of trading on Thursday, March 5, 2026. Earnings Conference Call Details An earnings conference call and live audio webcast will be hosted Friday, March 6, 2026, at 10:00 AM ET. Participants can register and receive dial-in information at https://register-conf.media-server.com/register/BI5b52747f39b248e6bdb12a6e39cbfd09. A live audio webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/u2f5cgxh or via the investor relations section of the

    2/6/26 8:36:12 AM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profilePriovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for brepocitinib New Drug Application (NDA) was submitted to the FDA for brepocitinib in dermatomyositis (DM). Topline data from Phase 3 studies in non-infectiou

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Marygold Companies Reports Financial Results For its Second Fiscal Quarter Ended December 31, 2025

    The Marygold Companies, Inc. (the "Company") (NYSE:MGLD), a global holding firm with a focus on financial services, today reported financial results for its second fiscal quarter ended December 31, 2025. Revenue for the three months ended December 31, 2025, amounted to $7.6 million, compared with the prior year period, when revenues were $8.0 million and which also included $0.6 million from Brigadier Security Systems (2000) Ltd. ("Brigadier"), a wholly owned subsidiary that was sold in July 2025 for $2.5 million. The Company's net loss for the quarter was $0.6 million as compared with a net loss of $1.7 million for the second quarter of the prior fiscal year. The $1.1 million improvement

    2/5/26 5:00:00 PM ET
    $MGLD
    Finance: Consumer Services
    Finance

    $ACLX
    $ADVM
    $AFCG
    $ALLK
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Rocket Companies Inc. on Jun 21

    Recently, there has been a series of insider purchases at Rocket Companies Inc. by Director Rizik Matthew. On 2024-06-21, Director Rizik Matthew made a purchase of $8,648 worth of shares, acquiring 622 units at a price of $13.90. This transaction increased his direct ownership by 0.09% to 706,108 units, as reported in SEC Form 4. This purchase indicates confidence from an insider in the company's prospects. Building up to this latest purchase, Rizik Matthew had also bought shares in the previous month. On 2024-05-31, he acquired $4,375 worth of shares (317 units at $13.80), increasing his direct ownership by 0.05% to 702,497 units. Following this, he made purchases on 2024-06-05, 2024-06-07

    6/22/24 7:57:56 PM ET
    $RKT
    Finance: Consumer Services
    Finance

    Insider Analysis: Purchase at Rocket Companies Inc. on Jun 7

    Rizik Matthew, a prominent figure at Rocket Companies Inc., has been steadily increasing his direct ownership in the company through a series of insider purchases over the past couple of months. The most recent purchase, which took place on June 7, 2024, saw Rizik Matthew acquiring $8,630 worth of shares, equivalent to 602 units at $14.34 per share. This transaction resulted in a marginal increase in his direct ownership by 0.09%, bringing his total direct ownership to 703,727 units as reported in the SEC Form 4. When we examine the pattern of Rizik Matthew's insider purchases leading up to the latest transaction, we can observe a consistent trend of incremental increases in direct ownershi

    6/10/24 12:42:26 AM ET
    $RKT
    Finance: Consumer Services
    Finance